Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Multiple Myeloma Trial in Patients With Bone Metastases

ClinicalTrials.gov ID: NCT00104104

Public ClinicalTrials.gov record NCT00104104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter,Open Label, Randomized Trial Evaluating the Duration of Infusion of Zoledronic Acid 4 mg IV in Multiple Myeloma Patients With Bone Metastases

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to study the safety of treating patients with multiple myeloma and at least one bone lesion with zoledronic acid 4mg intravenously (IV) every 3 - 4 weeks for 2 years. Patients will receive a zoledronic acid infusion for 15 minutes or 30 minutes.

Study identification

NCT ID
NCT00104104
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
179 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Sep 30, 2007
Completion
Sep 30, 2007
Last update posted
Jun 28, 2011

2004 – 2007

United States locations

U.S. sites
68
U.S. states
29
U.S. cities
64
Facility City State ZIP Site status
Hematology Oncology Specialists Huntsville Alabama 35801
Palo Verde Hematology Oncology Glendale Arizona 85304
US Oncology Tucson Arizona 85710
Myeloma Institute For Research Therapy Little Rock Arkansas 72205
University of Arkansas Little Rock Arkansas 72205
Pacific Cancer Medical Center Anaheim California 92801
Comprehensive Blood and Cancer Center Bakersfield California 93309
Southbay Oncology Hematology Partners Campbell California 95008
Bay Area Cancer Research Group Concord California 94520
California Oncology of the Central Valley Fresno California 93710
Dr. Robert P. Brouillard Inc. La Jolla California 92037
Antelope Valley Cancer Center Lancaster California 93534
Pacific Shores Medical Group Long Beach California 90813
North Valley H/O Mission Hills California 91345
Hematology/Oncology Group of Orange County Orange California 92868
Desert Hematology Oncology Medical Group Rancho Mirage California 92270
Camino Medical Group Sunnyvale California 94086
Oncotherapeutics West Hollywood California 90069
Greeley Medical Center Greeley Colorado 80631
Florida Cancer Specialists Fort Meyers Florida 33901
South Florida Oncology Hematology Hollywood Florida 33021
Osceola Cancer Center Kissimmee Florida 34741
Miami Cancer Care Miami Florida 33133
Pasco Hernado Oncology New Port Richey Florida 34652
MetCare Oncology Ormond Beach Florida 32174
Hematology Oncology Associates PA Pensacola Florida 32501
Hem/Onc Associates of Central Brevard Rockledge Florida 32955
Augusta Oncology Associates Augusta Georgia 30901
Georgia Cancer Specialists Tucker Georgia 30084
Cancer Care Center New Albany Indiana 47150
Hutchinson Clinic, PA Hutchinson Kansas 67502
Hematology and Oncology Specialists New Orleans Louisiana 70115
Maine Center for Cancer Medicine - Blood Disorders Scarborough Maine 04074
Center for Cancer and Blood Disorders Bethesda Maryland 20817
Oncology Hematology Associates, PA Clinton Maryland 20735
Maryland Oncology-Hematology PA Columbia Maryland 21044
Hematology Oncology Associates of Ohio & Michigan Lambertville Michigan 48144
Providence Cancer Center, Clinical Trials Dept Southfield Michigan 48075
Kansas City Cancer Center Kansas City Missouri 64131
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507
The Center for Cancer Care and Research St Louis Missouri 63141
Nebraska Methodist Hospital Omaha Nebraska 68114
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109
Nevada Cancer Center Las Vegas Nevada 89128
Center for Cancer & Hematology Disease Cherry Hill New Jersey 08003
Central Jersey Oncology Center East Brunswick New Jersey 08816
Hackensack University Medical Center Hackensack New Jersey 07601
CINJ at Cooper University Hospital Voorhees Township New Jersey 08043
New Mexico Cancer Care Associates Santa Fe New Mexico 87505
Hematology Oncology of Western Suffolk Bay Shore New York 11706
New York Presbyterian Hospital New York New York 10021
Syracuse Hematology/Oncology PC Syracuse New York 13210
Dayton Oncology & Hematology, PA Kettering Ohio 45409
University of Pennsylvania, Philadelphia Philadelphia Pennsylvania 19104
Pennsylvania Oncology Associates Philadelphia Pennsylvania 19106
Berks Oncology and Hematology Associates West Reading Pennsylvania 19611
Hematology & Oncology Associates of RI Cranston Rhode Island 02920
Roger Williams Hospital Medical Center Providence Rhode Island 02908
Charleston Hematology Oncology Charleston South Carolina 29403
Baptist Regional Cancer Center Knoxville Tennessee 37920
Center for Oncology Research & Treatment, PA Dallas Texas 75230
UT Southwestern Medical Center Dallas Texas 75390-9179
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410
Utah Hematology Oncology Ogden Utah 84403
Oncology Hematology Associates of Southwest VA Salem Virginia 24153
Western Washington Oncology Lacey Washington 98503
Swedish Cancer Institute Seattle Washington 98104
Fox Valley Hematology Oncology SC Appleton Wisconsin 54915

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00104104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2011 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00104104 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →